John Robert Wilson bought stock once, on Mar 16, 2021
Director at Marker Therapeutics, Inc., and 1 other company
SEC CIK 0001755569 · Filings on SEC.gov ↗
John Robert Wilson's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Companies
Every filing
2 filings since Mar 2021, newest first
About John Robert Wilson
Wilson John Robert is a corporate insider and former Director of Marker Therapeutics, Inc. (MRKR), a clinical‑stage immuno‑oncology company focused on next‑generation T‑cell–based therapies.( Regulatory filings identify him under CIK 1755569 and list his role as Director of Marker Therapeutics at the time of his reported trading activity.( As a board‑level insider, his transactions in Marker Therapeutics stock have been reported to the U.S. Securities and Exchange Commission, reflecting his access to material, non‑public information in the ordinary course of board service.(
Publicly available records on Wilson John Robert are largely limited to his insider‑trading disclosures and role designation, and do not provide a detailed professional background, specific career milestones, or educational history beyond his position as Director of Marker Therapeutics.( Based on the structure of the records and the CIK registration as an individual filer, he is a Person (individual) rather than a corporate or institutional entity.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.